SlideShare a Scribd company logo
1 of 86
Drug risk assessment & Pharmacoepidemiology Rob Heerdink 23 April 2010
Dr Rob Heerdink Pharmacoepidemiology & Pharmacotherapy Utrecht Institute for Pharmaceutical Sciences Universiteit Utrecht The Netherlands www.pharm.uu.nl/epithera
Drug development discovery Discovery & screening Proof of Concept first administration to man registration & launch approx.  10-12 years 10,000 Pre-clinical development 15-30 Fase I/IIa 10-15 Fase IIb/III 1 5 preclinical clinical (I-III) phase IV
Science 2005; 307: 196-8.
Phase I to III research not very informative on safety ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2 types of side effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2 types of side effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pre-occupation with type B side effects  (“tabloids”) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why do we know so little about side effects of drugs? ,[object Object],[object Object],[object Object],[object Object],[object Object]
A numbers game Clinical trials Market
Too  small ,[object Object],[object Object],[object Object],[object Object]
Sample size requirement in RCT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The likelihood of observing an adverse drug reaction employing numbers usually studied in premarketing trials Number of Patients Threshold for ADR Probability 2,000 1 / 500 0.98 (Lymphoma From Azathioprine)  1 / 1,000 0.86 (Eye Damage From Practolol)   1 / 10,000 0.18 (Anaphylaxis From Penicillin)   1 / 50,000 0.04  (Aplastic Anemia From Chloramphenicol)   Lembit Rägo, WHO Upsala
Too  short
 
Herald Tribune 30-09-96
“ It was easy money during the first trial, but that spinal tap really hurt.” Herald Tribune 30-09-96
Real patients ,[object Object]
Real patients ,[object Object],[object Object]
Real patients ,[object Object],[object Object],[object Object]
Real patients ,[object Object],[object Object],[object Object],[object Object],[object Object],geen 1 >1
Real patients ,[object Object],[object Object],[object Object],[object Object],[object Object]
Are Subjects in Pharmacological Treatment Trials of Depression Representative of Patients in Routine Clinical Practice? Mark Zimmerman, M.D.,  Jill I. Mattia, Ph.D., and  Michael A. Posternak, M.D Am J Psychiatry 159:469-473, March 2002 ‘ Of 346 patients with ‘major depression’ only 14% are eligible according to inclusioncriteria for trials with antidepressants’
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0  Clozapine (Novartis) 1  / 0 1  / 0
comparator Heres et al. Am J Psych, Feb 2006  sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5  / 0 2  / 1  2  / 0 1  / 0 Risperidon (Janssen) 3  / 1 1  / 0  Clozapine (Novartis) 1  / 0 1  / 0 Ziprasidone (Pfizer) 1  / 1 Amisulpiride (Sanofi) 1  / 0
RCTs ,[object Object],[object Object]
RCTs ,[object Object],[object Object],[object Object],[object Object],[object Object]
evidence based medicine ?
pharmacoepidemiology medicine based evidence
 
Relevant questions in practice following registration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evaluation of therapy: golden standard Randomised Controlled Clinical Trial (RCT) Randomise: why?  Controlgroup: why? Blinding: why? Goal: Only difference between treated and untreated  group is the treatment
Experiments are often impossible Ethical (e.g. smoking, birth defects) Practical (e.g. rare adverse effects) Non-experimental (observational) research For example: Do animals bite more often during full moon?
Do animals bite more during a full moon? Bhattacharjee C et al. BMJ 2000;321:1559-61
DOMAIN Determinant(s) Endpoint(s) time ,[object Object],[object Object],[object Object],Study design
Pharmacoepidemiological designs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Observational studies Past   Present    Future Retrospective Cohort Prospective Cohort Case-Control (retrospective) Cross-sectional
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Lancet, 1961
LETTER TO THE EDITOR THALIDOMIDE AND CONGENITAL ABNORMALITIES Sir, Congenital disorders are present in  approximately 1.5% of babies. In recent months  I have observed that the incidence of multiple  severe abnormalities in babies delivered of  women who were given the drug thalidomide  ('Distaval') during pregnancy,as an anti-emetic  or as a sedative, to be almost 20%. Have any of your readers seen similar  abnormalities in babies delivered of women  who have taken this drug during pregnancy? McBride WG. The Lancet, December 16, 1961: page 1358
Example  cross-sectional study Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication Gregoor et al  J Clin Psychopharmacol (in press) Research question:  are LEPR polymorphisms associated with increased BMI in antipsychotic users Study design:  cross-sectional
Example :  LEPR study Population: 200 patients using antipsychotics Determinants:  LEPR  Q223R and  LEP  promoter 2548G/A SNP polymorphisms Outcome: BMI
Example :  LEPR study ** p<0.05 N BMI>30 Males QQ 30 6 (20%) QR 73 16 (21%) RR 31 8 (26%) Females QQ 17 12 (71%) ** QR 39 15 (39%) QR 10 4 (40%)
Indexed prevalence and incidence per year of antidepressant use during 1992-2001 (1992=1).   Meijer et al.  Eur J Clin Pharmacol (2004) 60: 57–61
Observational Cohort ,[object Object]
 
Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
A cohort study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Merlo J, et al. BMJ 1996;313:457-61.
Another cohort study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Klungel et al. Epidemiology 2001;12:339-34 4.
Follow up study versus RCT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Follow-up studies more vulnerable to bias
Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
Case-control study Study Population Cases Controls Exposed Non-exposed Exposed Non-exposed
Example case-control study ,[object Object],[object Object],[object Object],[object Object]
Coogan et al. Am J Epidemiol 2005
Meijer et al. Arch Int Med 2004
Selection of cases ,[object Object],[object Object],[object Object],[object Object]
Selection of cases ,[object Object],[object Object],[object Object],[object Object]
Selection of Controls ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of Controls ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Ascertainment of outcome and exposure status ,[object Object],[object Object],[object Object],[object Object]
Prospective vs. retrospective Cohort Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of the Exposed Population ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Selection of the Comparison Population ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Collection External Data Sources Internal Data Sources Exposure Hospital records, employers Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Event Disease registries, death certificates, physician and hospital records  Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Confounder Hospital records registries Questionnaires, physical examinations
Bias ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Strengths in Cohort vs. Case-control? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations in Cohort vs. Case-control? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk assessment
 
Registration of a drug is only the beginning of safety research
Practical exercise ,[object Object],[object Object]
N Engl J Med 2006;354:579-87
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
Practical exercise ,[object Object]
Practical exercise ,[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Design ,[object Object],[object Object]

More Related Content

What's hot

Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Ahmad Ali
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research projectSai Kumar
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Devguest41e570
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillanceRamavath Aruna
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial rx_sonali
 
Pharmacoepidemology by K bennett
Pharmacoepidemology by K bennettPharmacoepidemology by K bennett
Pharmacoepidemology by K bennettSuvarta Maru
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyGovind Girase
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2RobHeerdink
 
Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studiesSamir Haffar
 
Clinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceClinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceRamavath Aruna
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyAsma Ashraf
 
Journal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyJournal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyOMICS International
 

What's hot (20)

Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research project
 
Pharmacoepideiology
PharmacoepideiologyPharmacoepideiology
Pharmacoepideiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
David Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug DevDavid Neasham Practical Use Pharmacoepi Drug Dev
David Neasham Practical Use Pharmacoepi Drug Dev
 
Clincal trails phases
Clincal trails  phasesClincal trails  phases
Clincal trails phases
 
Active and passive survillance
Active and passive survillanceActive and passive survillance
Active and passive survillance
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial
 
Pharmacoepidemology by K bennett
Pharmacoepidemology by K bennettPharmacoepidemology by K bennett
Pharmacoepidemology by K bennett
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
 
Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2
 
Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studies
 
Clinical Trail and Pharmacovigilance
Clinical Trail and PharmacovigilanceClinical Trail and Pharmacovigilance
Clinical Trail and Pharmacovigilance
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Clincial trials and types
Clincial trials and typesClincial trials and types
Clincial trials and types
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Journal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug SafetyJournal of Advances in Pharmacoepidemiology and Drug Safety
Journal of Advances in Pharmacoepidemiology and Drug Safety
 

Similar to Drug Risk Assessment Studies

College 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekCollege 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekRobHeerdink
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Mina Max
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized MedicineMichel Dumontier
 
Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Flavio Guzmán
 
Medical Literature
Medical Literature		Medical Literature
Medical Literature Khalid
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans GovindMishra61
 
Tapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsTapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsPaul Coelho, MD
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation Group Health Cooperative
 
Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Chaithanya Malalur
 
WFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeWFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeJP Rajendran
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsmack2286
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsmack2286
 
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...European School of Oncology
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...European School of Oncology
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Joost Burger
 

Similar to Drug Risk Assessment Studies (20)

College 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoekCollege 1e jaars Fase IV geneesmiddelenonderzoek
College 1e jaars Fase IV geneesmiddelenonderzoek
 
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
Chemotherapy+with+or+without+gefitinib+in+patients+with+advanced+non small-ce...
 
New pattern clinical study
New pattern clinical studyNew pattern clinical study
New pattern clinical study
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Tribestan 2015
Tribestan 2015Tribestan 2015
Tribestan 2015
 
Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007Module 4 Submodule 4. 2 Final June 2007
Module 4 Submodule 4. 2 Final June 2007
 
Medical Literature
Medical Literature		Medical Literature
Medical Literature
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans
 
Nocebo In FMS
Nocebo In FMSNocebo In FMS
Nocebo In FMS
 
Tapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin KrebsTapering Meta-Analysis Erin Krebs
Tapering Meta-Analysis Erin Krebs
 
State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation State of the evidence on chronic opioid therapy and risk mitigation
State of the evidence on chronic opioid therapy and risk mitigation
 
Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)Phase 0 Clinical Trials (microdosing)
Phase 0 Clinical Trials (microdosing)
 
WFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof GrunzeWFSBP Guidelines Mania - Prof Grunze
WFSBP Guidelines Mania - Prof Grunze
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medications
 
Stability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medicationsStability of active ingredients in lon expired prescription medications
Stability of active ingredients in lon expired prescription medications
 
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
Medical Students 2011 - J.B. Vermorken - INTRODUCTION TO CANCER TREATMENT - I...
 
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
Medical Students 2010 - Slide 5 - J.B. Vermorken - Introduction to Clincial T...
 
Ldn2020 pw
Ldn2020 pwLdn2020 pw
Ldn2020 pw
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)
 

More from RobHeerdink

College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011RobHeerdink
 
Adherence in elderly
Adherence in elderlyAdherence in elderly
Adherence in elderlyRobHeerdink
 
Workshop kuopio 2010
Workshop kuopio 2010Workshop kuopio 2010
Workshop kuopio 2010RobHeerdink
 
AHC 26 Januari 2010
AHC 26 Januari 2010AHC 26 Januari 2010
AHC 26 Januari 2010RobHeerdink
 
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
Psychofarmaca In De Dagelijkse Praktijk   Evidence BasedPsychofarmaca In De Dagelijkse Praktijk   Evidence Based
Psychofarmaca In De Dagelijkse Praktijk Evidence BasedRobHeerdink
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met AntidepressivaRobHeerdink
 

More from RobHeerdink (6)

College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011College Forensische Jeugdpsychiatrie - 7 januari 2011
College Forensische Jeugdpsychiatrie - 7 januari 2011
 
Adherence in elderly
Adherence in elderlyAdherence in elderly
Adherence in elderly
 
Workshop kuopio 2010
Workshop kuopio 2010Workshop kuopio 2010
Workshop kuopio 2010
 
AHC 26 Januari 2010
AHC 26 Januari 2010AHC 26 Januari 2010
AHC 26 Januari 2010
 
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
Psychofarmaca In De Dagelijkse Praktijk   Evidence BasedPsychofarmaca In De Dagelijkse Praktijk   Evidence Based
Psychofarmaca In De Dagelijkse Praktijk Evidence Based
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 

Recently uploaded

Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowRiya Pathan
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girlsnehamumbai
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment BookingHousewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...narwatsonia7
 

Recently uploaded (20)

Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment BookingHousewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
Housewife Call Girls Hoskote | 7001305949 At Low Cost Cash Payment Booking
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
 

Drug Risk Assessment Studies

  • 1. Drug risk assessment & Pharmacoepidemiology Rob Heerdink 23 April 2010
  • 2. Dr Rob Heerdink Pharmacoepidemiology & Pharmacotherapy Utrecht Institute for Pharmaceutical Sciences Universiteit Utrecht The Netherlands www.pharm.uu.nl/epithera
  • 3. Drug development discovery Discovery & screening Proof of Concept first administration to man registration & launch approx. 10-12 years 10,000 Pre-clinical development 15-30 Fase I/IIa 10-15 Fase IIb/III 1 5 preclinical clinical (I-III) phase IV
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. A numbers game Clinical trials Market
  • 11.
  • 12.
  • 13. The likelihood of observing an adverse drug reaction employing numbers usually studied in premarketing trials Number of Patients Threshold for ADR Probability 2,000 1 / 500 0.98 (Lymphoma From Azathioprine) 1 / 1,000 0.86 (Eye Damage From Practolol) 1 / 10,000 0.18 (Anaphylaxis From Penicillin) 1 / 50,000 0.04 (Aplastic Anemia From Chloramphenicol) Lembit Rägo, WHO Upsala
  • 15.  
  • 17. “ It was easy money during the first trial, but that spinal tap really hurt.” Herald Tribune 30-09-96
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Are Subjects in Pharmacological Treatment Trials of Depression Representative of Patients in Routine Clinical Practice? Mark Zimmerman, M.D., Jill I. Mattia, Ph.D., and Michael A. Posternak, M.D Am J Psychiatry 159:469-473, March 2002 ‘ Of 346 patients with ‘major depression’ only 14% are eligible according to inclusioncriteria for trials with antidepressants’
  • 24. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0
  • 25. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0
  • 26. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0 Clozapine (Novartis) 1 / 0 1 / 0
  • 27. comparator Heres et al. Am J Psych, Feb 2006 sponsored drug olanzapine risperidon clozapine ziprasidone ami sulpiride Olanzapine (Lilly) 5 / 0 2 / 1 2 / 0 1 / 0 Risperidon (Janssen) 3 / 1 1 / 0 Clozapine (Novartis) 1 / 0 1 / 0 Ziprasidone (Pfizer) 1 / 1 Amisulpiride (Sanofi) 1 / 0
  • 28.
  • 29.
  • 32.  
  • 33.
  • 34. Evaluation of therapy: golden standard Randomised Controlled Clinical Trial (RCT) Randomise: why? Controlgroup: why? Blinding: why? Goal: Only difference between treated and untreated group is the treatment
  • 35. Experiments are often impossible Ethical (e.g. smoking, birth defects) Practical (e.g. rare adverse effects) Non-experimental (observational) research For example: Do animals bite more often during full moon?
  • 36. Do animals bite more during a full moon? Bhattacharjee C et al. BMJ 2000;321:1559-61
  • 37.
  • 38.
  • 39. Observational studies Past Present Future Retrospective Cohort Prospective Cohort Case-Control (retrospective) Cross-sectional
  • 40.
  • 42. LETTER TO THE EDITOR THALIDOMIDE AND CONGENITAL ABNORMALITIES Sir, Congenital disorders are present in approximately 1.5% of babies. In recent months I have observed that the incidence of multiple severe abnormalities in babies delivered of women who were given the drug thalidomide ('Distaval') during pregnancy,as an anti-emetic or as a sedative, to be almost 20%. Have any of your readers seen similar abnormalities in babies delivered of women who have taken this drug during pregnancy? McBride WG. The Lancet, December 16, 1961: page 1358
  • 43. Example cross-sectional study Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication Gregoor et al J Clin Psychopharmacol (in press) Research question: are LEPR polymorphisms associated with increased BMI in antipsychotic users Study design: cross-sectional
  • 44. Example : LEPR study Population: 200 patients using antipsychotics Determinants: LEPR Q223R and LEP promoter 2548G/A SNP polymorphisms Outcome: BMI
  • 45. Example : LEPR study ** p<0.05 N BMI>30 Males QQ 30 6 (20%) QR 73 16 (21%) RR 31 8 (26%) Females QQ 17 12 (71%) ** QR 39 15 (39%) QR 10 4 (40%)
  • 46. Indexed prevalence and incidence per year of antidepressant use during 1992-2001 (1992=1). Meijer et al. Eur J Clin Pharmacol (2004) 60: 57–61
  • 47.
  • 48.  
  • 49. Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
  • 50.
  • 51.
  • 52.
  • 53. Cohort study / Follow-up study Study population Exposed Non-exposed Disease + Disease + Disease - Disease -
  • 54. Case-control study Study Population Cases Controls Exposed Non-exposed Exposed Non-exposed
  • 55.
  • 56. Coogan et al. Am J Epidemiol 2005
  • 57. Meijer et al. Arch Int Med 2004
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66. Data Collection External Data Sources Internal Data Sources Exposure Hospital records, employers Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Event Disease registries, death certificates, physician and hospital records Questionnaires, physical examinations, and/or blood tests, other diagnostic tests Confounder Hospital records registries Questionnaires, physical examinations
  • 67.
  • 68.
  • 69.
  • 71.  
  • 72. Registration of a drug is only the beginning of safety research
  • 73.
  • 74. N Engl J Med 2006;354:579-87
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.  
  • 80.  
  • 81.  
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.

Editor's Notes

  1. Scok door de wereld Rozen ook doornen Final trigger betekende echter niet het einde
  2. A cohort study is a study where a group of individuals are followed. The study population is defined on basis on the presence or absence of exposure to a suspected risk factor for a disease. The cohort studies is either classified as a prospective or a retrospective study. The definition is based on the time of occurrence of the disease according to the initiation of the study. In the prospective studies the disease of interest is never occurred at initiation, the exposure are either presence at the beginning of the study or it can occur later. The prospective cohort you have to follow over time. In the retrospective cohort study, all the relevant events disease and exposure have occurred before the initiation of the study. outcome follow- up retrospective/prospective Protocol: study objectives, design choices, performance goals, monitoring and analysis procedures Manual of procedures/log book Centralised training of key personnel
  3. A cohort study is a study where a group of individuals are followed. The study population is defined on basis on the presence or absence of exposure to a suspected risk factor for a disease. The cohort studies is either classified as a prospective or a retrospective study. The definition is based on the time of occurrence of the disease according to the initiation of the study. In the prospective studies the disease of interest is never occurred at initiation, the exposure are either presence at the beginning of the study or it can occur later. The prospective cohort you have to follow over time. In the retrospective cohort study, all the relevant events disease and exposure have occurred before the initiation of the study. outcome follow- up retrospective/prospective Protocol: study objectives, design choices, performance goals, monitoring and analysis procedures Manual of procedures/log book Centralised training of key personnel
  4. Population based: All subjects with the disease in the study base or a random sample
  5. Start med side 137 H&amp;B Controls should be a part of the study base, not represent the entire non diseased population but the population of individuals who would have been identified and included as cases had they also developed the disease. Principles of Control selection Study base: Controls can be used to characterise the distribution of exposure Comparable-accuracy Equal reliability in the information obtained from cases and controls  no differential misclassification Deconfounding Elimination of confounding through control selection  matching or stratified sampling Those principles should not be regarded as absolute, but rather as points to consider in choosing a control group
  6. About interviews se side 143 H&amp;B,
  7. The prospective study is time consuming and therefore expensive on the other hand it is possible to have valid information on exposure, because it isn.t